S-adenosyl-L-homocysteine hydrolase as an attractive target for antimicrobial drugs

Yakugaku Zasshi

Volumn 127, Issue 6, 2007, Pages 977-982

  Nakanishi, Masayuki ^a  

^a GIFU UNIVERSITY   (Japan)

Author keywords

Antimalarial; Antiviral; Fine tuning; Nucleoside inhibitor; Plasmodium falciparum; S adenysylhomocysteine

Indexed keywords

ADENOSYLHOMOCYSTEINASE; ANTIINFECTIVE AGENT; ANTIMALARIAL AGENT; NUCLEOSIDE ANALOG;

ANTIMALARIAL ACTIVITY; CELL CULTURE; CHEMOTHERAPY; CRYSTAL STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; GROWTH INHIBITION; MALARIA; MUTAGENESIS; NONHUMAN; PLASMODIUM; PLASMODIUM FALCIPARUM; REVIEW; STRUCTURE ANALYSIS; TOXICITY;

ADENOSYLHOMOCYSTEINASE; ANIMALS; ANTIMALARIALS; ANTIVIRAL AGENTS; DRUG DESIGN; ENZYME INHIBITORS; HUMANS; PLASMODIUM FALCIPARUM; S-ADENOSYLHOMOCYSTEINE;

EID: 34249817888     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.127.977     Document Type: Review

References (25)

1. Cantoni G. L., "Biological Methylation and Drug Design," eds. by Borchardt R. T., Creveling C. R., Ueland P. M., Humana Press, NJ, 1986, pp. 227-238.
2. Brosnan J. T., Brosnan M. E., J. Nutr., 136, 1636S-1640S (2006).
3. Stepkowski T., Brzezinski K., Legocki A. B., Jaskolski M., Bena G., Mol. Phylogen. Evol., 34, 15-28 (2005).
4. Miller M. W., Duhl D. M. J., Winkes B. M., Arredondo-Vega F., Saxon P. J., Wolff G. L., Epstein C. J., Hershfield M. S., Barsh G. S., EMBO J., 13, 1806-1816 (1994).
5. Baric I., Fumic K., Glenn B., Cuk M., Schulze A., Finkerlstein J. D., Jill James S., Mejaski-Bosnjak V., Pazanin L., Pogribny I. P., Rados M., Sarnavka V., Scukanec-Spoljar M., Allen R. H., Stabler S., Uzelac L., Vugrek O., Wagner C., Zeisel S., Mudd S. H., Proc. Natl. Acad. Sci. U.S.A, 101, 4234-4239 (2004).
6. De Clercq E., Nat. Rev. Microbiol., 2, 704-720 (2004).
7. Stoltzfus C. M., Montgomery J. A., J. Virol., 38, 173-183 (1981).
8. Chiang P. K., "Nucleic Acid Methylation," eds. by Clawson G. A., Willis D. B., Weissbach A., Jones P. A., Wiley-Liss, New York, 1990, pp. 247-255.
9. De Clercq E., Descamps J., De Somer P., Holy A., Science, 200, 563-565 (1978).
10. Kitade Y., Nakanishi M., Yatome C., Bioorg. Med. Chem. Lett., 9, 2737-2740 (1999).
11. Yaginuma S., Muto N., Tsujino N., Sudate Y., Hayashi M., Otani M., J. Antibiot., 34, 359-366 (1981).
12. Kusaka T., Yamamoto H., Shibata M., Muroi M., Kishi T., J. Antibiot., 21, 255-263 (1968).
13. Whaun J. M., Miura G. A., Brown N. D., Gordon R. K., Chiang P. K., J. Pharmacol. Exp. Ther., 236, 277-283 (1986).
14. Bitonti A. J., Baumann R. J., Jarvi E. T., McCarthy J. R., McCann P. P., Biochem. Pharmacol., 40, 601-606 (1990).
15. Creedon K. A., Rathod P. K., Wellems T. E., J. Biol. Chem., 269, 16364-16370 (1994).
16. Nakanishi M., Iwata A., Yatome C., Kitade Y., J. Biochem., 129, 101-105 (2001).
17. Siddiqi S. M., Chen X., Schneller S. W., J. Med. Chem., 37, 551-554 (1994).
18. Kitade Y., Kozaki A., Miwa Y., Nakanishi M., Tetrahedron, 58, 1271-1277 (2002).
19. Kitade Y., Kojima H., Zulfiqar F., Kim H.-S., Wataya Y., Bioorg. Med. Chem. Lett., 13, 3963-3965 (2003).
20. Tanaka N., Kusakabe Y., Shiraiwa K., Sakamoto Y., Nakanishi M., Kitade Y., Nakamura K. T., Protein Pept. Lett., 11, 201-205 (2004).
21. Tanaka N., Nakanishi M., Kusakabe Y., Shiraiwa K., Yabe S., Ito Y., Kitade Y., Nakamura K. T., J. Mol. Biol., 343, 1007-1017 (2004).
22. Turner M. A., Yuan C.-S., Borchardt R. T., Hershfield M. S., Smith G. D., Howell P. L., Nat. Struct. Biol., 5, 369-376 (1998).
23. Nakanishi M., Yabe S., Tanaka N., Ito Y., Nakamura K. T., Kitade Y., Mol. Biochem. Parasitol., 143, 146-151 (2005).
24. Hu Y., Yang X., Yin D. H., Mahadevan J., Kuczera K., Schowen R. L., Borchardt R. T., Biochemistry, 40, 15143-15152 (2001).
25. Kitade Y., Ando T., Yamaguchi T., Hori A., Nakanishi M., Ueno Y., Bioorg. Med. Chem., 14, 5578-5583 (2006).